- Home
- ELDN vs AFRI Comparison
ELDN vs AFRI Comparison
Compare ELDN & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- AFRI
- Stock Information
- Founded
- ELDN 2004
- AFRI 1943
- Country
- ELDN United States
- AFRI Gibraltar
- Employees
- ELDN N/A
- AFRI N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- AFRI Packaged Foods
- Sector
- ELDN Health Care
- AFRI Consumer Staples
- Exchange
- ELDN Nasdaq
- AFRI Nasdaq
- Market Cap
- ELDN 202.4M
- AFRI 207.7M
- IPO Year
- ELDN N/A
- AFRI N/A
- Fundamental
- Price
- ELDN $2.63
- AFRI $7.89
- Analyst Decision
- ELDN Strong Buy
- AFRI
- Analyst Count
- ELDN 2
- AFRI 0
- Target Price
- ELDN $12.50
- AFRI N/A
- AVG Volume (30 Days)
- ELDN 1.0M
- AFRI 10.7K
- Earning Date
- ELDN 08-14-2025
- AFRI 08-22-2025
- Dividend Yield
- ELDN N/A
- AFRI N/A
- EPS Growth
- ELDN N/A
- AFRI N/A
- EPS
- ELDN 0.21
- AFRI N/A
- Revenue
- ELDN N/A
- AFRI $274,223,000.00
- Revenue This Year
- ELDN N/A
- AFRI N/A
- Revenue Next Year
- ELDN N/A
- AFRI N/A
- P/E Ratio
- ELDN $12.40
- AFRI N/A
- Revenue Growth
- ELDN N/A
- AFRI N/A
- 52 Week Low
- ELDN $2.38
- AFRI $7.47
- 52 Week High
- ELDN $5.54
- AFRI $11.80
- Technical
- Relative Strength Index (RSI)
- ELDN 36.28
- AFRI 58.04
- Support Level
- ELDN $2.54
- AFRI $7.70
- Resistance Level
- ELDN $2.82
- AFRI $8.06
- Average True Range (ATR)
- ELDN 0.21
- AFRI 0.20
- MACD
- ELDN -0.08
- AFRI 0.02
- Stochastic Oscillator
- ELDN 20.00
- AFRI 71.19
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.